These results showed that CSF1 treatment ameliorates Aβ plaques accumulation in the Trem2-/-; 5XFAD mouse brain, indicating that activation of the CSF1R signaling pathway maybe a therapeutic strategy in AD treatment. The gene discussed is CSF1R; the disease is Alzheimer disease.